Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2021-01-12 | Bizongo | Unattributed VC | $9.3M | Accel, Chiratae Ventures, IDG Ventures, and International Finance Corporation |
2020-11-12 | Synendos Therapeutics | Series A | $21.86M | Bernina BioInvest, Essential Investment Partners, High-Tech Grunderfonds, Kurma Partners, Sunstone Capital, and Zurcher Kantonalbank |
2020-11-06 | Memo Therapeutics | Series B | $15.57M | Bernina BioInvest, investiere, Jaquet Partners, Redalpine Venture Partners, and Swisscanto Invest |
2020-10-22 | Araris Biotech | Series A | $16.77M | 4BIO Capital, btov Partners, Pureos Bioventures, Redalpine Venture Partners, and VI Partners |
2020-09-24 | Cedilla Therapeutics | Series B | $57.6M | Boxer Capital, Casdin Capital, Eli Lilly and Company, Third Rock Ventures, and Undisclosed Investors |